Covalent-101: A Phase 1 Study Of Bmf-219, A Novel Oral Irreversible Menin Inhibitor, In Patients With Relapsed/Refractory Acute Leukemia, Diffuse Large B-Cell Lymphoma, And Multiple Myeloma
Bmf-219
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Covalent-101: A Phase 1 Study Of Bmf-219, A Novel Oral Irreversible Menin Inhibitor, In Patients With Relapsed/Refractory Acute Leukemia, Diffuse Large B-Cell Lymphoma, And Multiple Myeloma ### Output: Bmf-219